Enquire Now
About Us

About Us

Aarti Pharmalabs Limited (APL) is an established, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, we integrate process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. We specialise in generic APIs, generic intermediates, and xanthine derivatives. We deliver CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. We have dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for our flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Our Vision

Our Vision

To emerge as a “global partner of choice” for leading consumers of Pharmaceutical and Nutraceutical products.


Our Mission

Sustainable delivery and business operations for our products and Services.

Our Journey

1984

Incorporated Aarti Industries Pvt Ltd

1992

Aarti Industries listed on NSE and BSE

2001

Started Pharma Division Commissioned R&D and API Manufacturing Unit in Dombivli (Unit 1) and started Xanthine unit

2005

Commissioned first API Manufacturing Unit in Tarapur (Unit 4)

2008

Completed the USFDA & EUGMP audits for Tarapur Unit 4

2009

Completed the USFDA audit at Intermediate facility (CSD) at Vapi Unit 2

2013

Received EUGMP approval for the Oncology block at Unit 4

2016

Commissioned Caffeine production at Unit 5 with a capacity of 100 (MT) per month

2017

Completed Cofepris, Mexico audit at Unit 4

2019

Completed audit by EDQM for the Oncology block at Unit 4

2022

Demerged the pharmaceutical business of Aarti Industries Ltd to Aarti Pharmalabs Ltd Secured USFDA approval for Dombivli Unit Expanded blocks Vapi and Tarapur units Acquired land at Atali for future growth

2023

Operationalized third R&D centre in Nerul Commercialized Block V at Tarapur Unit 4 Enhanced Xanthine capacity to 5,000 TPA

Values

Care
Care

Our devotion to caregiving spans all of our stakeholders, including our team members, clients, suppliers, local community, and the environment.

Integrity
Integrity

We consistently uphold the greatest moral and ethical principles.

Excellence
Excellence

We endeavour to gratify our clients and stakeholders.

Values

Accreditation

Qorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam eu turpis molestie, dictum est a, mattis tellus. Sed dignissim, metus nec fringilla accumsan, risus sem sollicitudin lacus, ut interdum tellus elit sed risus. Maecenas eget condimentum velit, sit amet feugiat lectus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Norem ipsum dolor sit amet, consectetur adipiscing elit. Etiam eu turpis molestie, dictum est a, mattis tellus.

See Details arrow
The members of our <br>leadership team

The members of our
leadership team

Explore arrow

Facilities

Our Head Office is located in Mumbai, India’s commercial capital and the largest city in the western region.

  • Head Office

    Mumbai

  • Sites

    Dombivli, Vapi, Tarapur, Atali

  • Port Near our Site

    Kandla, Nhava Sheva, Hazira, Dahej

Explore More

APL at a Glance

Products
200+

Products

Global Clients
500+

Global Clients

R&D Centers
2

R&D Centers

R&D Centers
6

R&D Centers

Employees
2000+

Employees

CEP
20

CEP

USDMF
40

USDMF

USFDA Units
3

USFDA Units

Let’s Build the Future of
Healthcare Together

Let’s Build the Future of
Healthcare Together

Contact Us arrow